News


Stay tuned and learn Genekor’s latest news and updates on Molecular Oncology.

13.09.2022

Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes

The study by the Genekor Scientific Team on "Cascade genetic testing utilized only in 31% of initial families with pathogenic variants in breast cancer genes" was presented at ESMO CONGRESS 2022 in the form of a Poster by Doctors Ziogas Dimitrios (Pathologist-Oncologist A Oncology Clinic Laiko Athens General Hospital) and Giassas Stylianos (Pathologist-Oncologist, Director B, Oncology Clinic, Iasso Hospital).

read more
11.05.2022

Updated ASCO Guidelines!

Updated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score® Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients.

read more
29.03.2022

New Molecular Assay - Signatera ™

The sooner you find out, the faster you can act. Knowing earlier matters

The first ctDNA molecular monitoring tool Worldwide.

New Molecular Assay - Signatera ™

Early Detection of residual disease at molecular level before relapse.

read more
Change cookies consent Revoke cookies consent